Evidence map›Paper›PMID 33149237›Full record

ArticleExperimental & molecular medicine2020

Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target.

Suji Han, Hyemi Shin, Jin-Ku Lee, Zhaoqi Liu, Raul Rabadan, Jeongwu Lee, Jihye Shin, Cheolju Lee, Heekyoung Yang, Donggeon Kim and 9 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental & molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Suji Han *Institute for Refractory Cancer Research, Research Institute for Future Medicine, Sungkyunkwan University, Seoul, Korea.
Hyemi Shin *Institute for Refractory Cancer Research, Research Institute for Future Medicine, Sungkyunkwan University, Seoul, Korea.
Jin-Ku Lee *Department of Biochemistry and Molecular Biology, Ajou University School of Medicine, Suwon, Korea.
Zhaoqi LiuDepartment of Systems Biology, Columbia University, New York, NY, USA.
Raul RabadanDepartment of Systems Biology, Columbia University, New York, NY, USA.
Jeongwu LeeDepartment of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Jihye ShinCenter for Theragnosis, BRI, Korea Institute of Science and Technology, Seoul, Korea.
Cheolju LeeCenter for Theragnosis, BRI, Korea Institute of Science and Technology, Seoul, Korea.
Heekyoung YangInstitute for Refractory Cancer Research, Research Institute for Future Medicine, Sungkyunkwan University, Seoul, Korea.
Donggeon KimInstitute for Refractory Cancer Research, Research Institute for Future Medicine, Sungkyunkwan University, Seoul, Korea.
Sung Heon KimInstitute for Refractory Cancer Research, Research Institute for Future Medicine, Sungkyunkwan University, Seoul, Korea.
Jooyeon KimInstitute for Refractory Cancer Research, Research Institute for Future Medicine, Sungkyunkwan University, Seoul, Korea.
Jeong-Woo OhInstitute for Refractory Cancer Research, Research Institute for Future Medicine, Sungkyunkwan University, Seoul, Korea.
Doo-Sik KongDepartment of Neurosurgery, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea.
Jung-Il LeeDepartment of Neurosurgery, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea.
Ho Jun SeolDepartment of Neurosurgery, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea.
Jung Won ChoiDepartment of Neurosurgery, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea.
Hyun Ju KangInstitute for Refractory Cancer Research, Research Institute for Future Medicine, Sungkyunkwan University, Seoul, Korea. hj0601.kang@gmail.com.
Do-Hyun NamInstitute for Refractory Cancer Research, Research Institute for Future Medicine, Sungkyunkwan University, Seoul, Korea. nsnam@skku.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33149237
PMCPMC8080829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.